Role of thrombolysis in reperfusion therapy for management of AMI: Indian scenario

Saved in:
Bibliographic Details
Published inIndian heart journal Vol. 65; no. 5; pp. 566 - 585
Main Authors Dalal, Jamshed, Sahoo, Prasant Kumar, Singh, Rakesh Kumar, Dhall, Anil, Kapoor, Rajneesh, Krishnamurthy, A., Shetty, Sadanand R., Trivedi, Shailendra, Kahali, Dhiman, Shah, Bhupesh, Chockalingam, K., Abdullakutty, Jabir, Shetty, Pradeep K., Chopra, Arun, Ray, Raja, Desai, Devang, Pachiyappan, Ratnaparkhi, Gajanan, Sharma, Mridul, Sambasivam, K.A.
Format Journal Article
LanguageEnglish
Published India Elsevier, a division of RELX India, Pvt. Ltd 01.09.2013
Elsevier
Subjects
AMI
CAD
Cardiovascular
Combined Modality Therapy
Coronary Artery Disease - diagnostic imaging
Coronary Artery Disease - drug therapy
Coronary Artery Disease - mortality
Evidence-Based Medicine
Female
Fibrinolytic Agents - adverse effects
Fibrinolytic Agents - therapeutic use
Hemorrhage - chemically induced
Hemorrhage - epidemiology
Humans
India
Male
Myocardial Infarction - diagnosis
Myocardial Infarction - drug therapy
Myocardial Infarction - mortality
Myocardial Infarction - therapy
Myocardial Reperfusion - methods
Prognosis
Radiography
Randomized Controlled Trials as Topic
Risk Assessment
Role
Sponsored
STEMI
Survival Analysis
Thrombolytic Therapy - adverse effects
Thrombolytic Therapy - methods
Thrombolytics in AMI
Treatment Outcome
STEMI
Thrombolytics in AMI
AMI
CAD
Online AccessGet full text
ISSN0019-4832
DOI10.1016/j.ihj.2013.08.032

Cover

Author Sambasivam, K.A.
Desai, Devang
Shetty, Sadanand R.
Shetty, Pradeep K.
Dalal, Jamshed
Kapoor, Rajneesh
Ray, Raja
Ratnaparkhi, Gajanan
Krishnamurthy, A.
Trivedi, Shailendra
Shah, Bhupesh
Sahoo, Prasant Kumar
Chockalingam, K.
Sharma, Mridul
Abdullakutty, Jabir
Singh, Rakesh Kumar
Pachiyappan
Kahali, Dhiman
Chopra, Arun
Dhall, Anil
AuthorAffiliation s Sterling Hospital, Rajkot, Gujarat, India
n Fortis Escorts Hospital, Amritsar, Punjab, India
i B. M. Birla Heart Research Centre, Kolkata, West Bengal, India
b Apollo Hospitals, Bhubneshwar, Orissa, India
r Criticare Hospital, Mumbai, Maharashtra, India
l Lisie Hospital, Cochin, Kerala, India
f Vijaya Health Care Centre and Hospital, Chennai, Tamil Nadu, India
k Kovai Medical Center and Hospital Limited, Coimbatore, Tamil Nadu, India
j Sterling Hospital, Ahmedabad, Gujarat, India
c Chirayu Cardiac Centre, Bhopal, Madhya Pradesh, India
m Narayana Hrudalaya Hospital, Bangalore, Karnataka, India
d Delhi Heart & Lung Institute, New Delhi, India
o AMRI Hospitals, Kolkata, West Bengal, India
t GKNM Hospital, Coimbatore, Tamil Nadu, India
e Medanta Medicity, Gurgaon, Haryana, India
g Sadanand Healthy Living Center, Mumbai, Maharashtra, India
h CHL Apollo Hospitals, Indore, Madhya Pradesh, India
q Manipal Hospital, Salem, Tamil Nadu, India
a Kokilaben Ambani Hospital, Mumbai, Maharashtra, India
p Mahaveer Card
AuthorAffiliation_xml – name: a Kokilaben Ambani Hospital, Mumbai, Maharashtra, India
– name: q Manipal Hospital, Salem, Tamil Nadu, India
– name: d Delhi Heart & Lung Institute, New Delhi, India
– name: e Medanta Medicity, Gurgaon, Haryana, India
– name: c Chirayu Cardiac Centre, Bhopal, Madhya Pradesh, India
– name: g Sadanand Healthy Living Center, Mumbai, Maharashtra, India
– name: h CHL Apollo Hospitals, Indore, Madhya Pradesh, India
– name: p Mahaveer Cardiac Hospital, Surat, Gujarat, India
– name: l Lisie Hospital, Cochin, Kerala, India
– name: b Apollo Hospitals, Bhubneshwar, Orissa, India
– name: j Sterling Hospital, Ahmedabad, Gujarat, India
– name: t GKNM Hospital, Coimbatore, Tamil Nadu, India
– name: r Criticare Hospital, Mumbai, Maharashtra, India
– name: n Fortis Escorts Hospital, Amritsar, Punjab, India
– name: k Kovai Medical Center and Hospital Limited, Coimbatore, Tamil Nadu, India
– name: i B. M. Birla Heart Research Centre, Kolkata, West Bengal, India
– name: f Vijaya Health Care Centre and Hospital, Chennai, Tamil Nadu, India
– name: m Narayana Hrudalaya Hospital, Bangalore, Karnataka, India
– name: o AMRI Hospitals, Kolkata, West Bengal, India
– name: s Sterling Hospital, Rajkot, Gujarat, India
Author_xml – sequence: 1
  givenname: Jamshed
  surname: Dalal
  fullname: Dalal, Jamshed
  email: trailokya_301279@yahoo.co.in, jjdalal@hotmail.com
  organization: Kokilaben Ambani Hospital, Mumbai, Maharashtra, India
– sequence: 2
  givenname: Prasant Kumar
  surname: Sahoo
  fullname: Sahoo, Prasant Kumar
  organization: Apollo Hospitals, Bhubneshwar, Orissa, India
– sequence: 3
  givenname: Rakesh Kumar
  surname: Singh
  fullname: Singh, Rakesh Kumar
  organization: Chirayu Cardiac Centre, Bhopal, Madhya Pradesh, India
– sequence: 4
  givenname: Anil
  surname: Dhall
  fullname: Dhall, Anil
  organization: Delhi Heart & Lung Institute, New Delhi, India
– sequence: 5
  givenname: Rajneesh
  surname: Kapoor
  fullname: Kapoor, Rajneesh
  organization: Medanta Medicity, Gurgaon, Haryana, India
– sequence: 6
  givenname: A.
  surname: Krishnamurthy
  fullname: Krishnamurthy, A.
  organization: Vijaya Health Care Centre and Hospital, Chennai, Tamil Nadu, India
– sequence: 7
  givenname: Sadanand R.
  surname: Shetty
  fullname: Shetty, Sadanand R.
  organization: Sadanand Healthy Living Center, Mumbai, Maharashtra, India
– sequence: 8
  givenname: Shailendra
  surname: Trivedi
  fullname: Trivedi, Shailendra
  organization: CHL Apollo Hospitals, Indore, Madhya Pradesh, India
– sequence: 9
  givenname: Dhiman
  surname: Kahali
  fullname: Kahali, Dhiman
  organization: B. M. Birla Heart Research Centre, Kolkata, West Bengal, India
– sequence: 10
  givenname: Bhupesh
  surname: Shah
  fullname: Shah, Bhupesh
  organization: Sterling Hospital, Ahmedabad, Gujarat, India
– sequence: 11
  givenname: K.
  surname: Chockalingam
  fullname: Chockalingam, K.
  organization: Kovai Medical Center and Hospital Limited, Coimbatore, Tamil Nadu, India
– sequence: 12
  givenname: Jabir
  surname: Abdullakutty
  fullname: Abdullakutty, Jabir
  organization: Lisie Hospital, Cochin, Kerala, India
– sequence: 13
  givenname: Pradeep K.
  surname: Shetty
  fullname: Shetty, Pradeep K.
  organization: Narayana Hrudalaya Hospital, Bangalore, Karnataka, India
– sequence: 14
  givenname: Arun
  surname: Chopra
  fullname: Chopra, Arun
  organization: Fortis Escorts Hospital, Amritsar, Punjab, India
– sequence: 15
  givenname: Raja
  surname: Ray
  fullname: Ray, Raja
  organization: AMRI Hospitals, Kolkata, West Bengal, India
– sequence: 16
  givenname: Devang
  surname: Desai
  fullname: Desai, Devang
  organization: Mahaveer Cardiac Hospital, Surat, Gujarat, India
– sequence: 17
  surname: Pachiyappan
  fullname: Pachiyappan
  organization: Manipal Hospital, Salem, Tamil Nadu, India
– sequence: 18
  givenname: Gajanan
  surname: Ratnaparkhi
  fullname: Ratnaparkhi, Gajanan
  organization: Criticare Hospital, Mumbai, Maharashtra, India
– sequence: 19
  givenname: Mridul
  surname: Sharma
  fullname: Sharma, Mridul
  organization: Sterling Hospital, Rajkot, Gujarat, India
– sequence: 20
  givenname: K.A.
  surname: Sambasivam
  fullname: Sambasivam, K.A.
  organization: GKNM Hospital, Coimbatore, Tamil Nadu, India
BackLink https://www.ncbi.nlm.nih.gov/pubmed/24206881$$D View this record in MEDLINE/PubMed
BookMark eNqFkl1rFDEUhnNRsR_6A7yR-QM75nuyCoVSql2oCLUX3oVM5mQ340yyJLOF_fdmulZswXoVyDnPE3Lec4qOQgyA0DuCa4KJ_NDXftPXFBNWY1VjRo_QCcZkueCK0WN0mnOPMRV8iV-jY8oplkqRE3R7GweooqumTYpjG4d99rnyoUqwheR22cdQapDMdl-5mKrRBLOGEcI0UxdfVx-rVei8CVW2EEzy8Q165cyQ4e3v8wzdfb66u7xe3Hz7srq8uFlYwRq64NZi54ykwLhkyoLFVgLpqFCmFZ3qDO0oNIw4xWRDGebAsGwkZpZLJdgZWh20XTS93iY_mrTX0Xj9cBHTWps0eTuANs1SCsNkyynjhDXGEk5bIxohWnDOFdf5wbXdtSN05SNTMsMT6dNK8Bu9jveaKUmwZEXw_m_BH_Jx0KWhOTTYFHNO4LT1k5nKdIvPD5pgPceoe11i1HOMGitdYiwkeUY-yl9iPh0YKPO_95B0th6Chc4nsFOZkH-RPn9G28EHb83wE_aQ-7hLoQSric5UY_19XrN5ywgrG6bEjyJY_lvwn8d_AaBI33I
CitedBy_id crossref_primary_10_36106_ijsr_2601395
crossref_primary_10_7759_cureus_12017
crossref_primary_10_1007_s11033_019_05167_x
crossref_primary_10_1007_s00210_023_02804_y
crossref_primary_10_26416_Gine_22_4_2018_2139
crossref_primary_10_37689_acta_ape_2020AR00946
crossref_primary_10_1002_phar_2025
crossref_primary_10_4103_jpcs_jpcs_106_20
Cites_doi 10.1136/hrt.2004.058529
10.1378/chest.08-0665
10.1093/eurheartj/18.suppl_F.2
10.1345/aph.18006
10.1186/1471-2261-9-28
10.1016/j.jacc.2007.04.084
10.1161/CIRCULATIONAHA.107.762765
10.1093/eurheartj/17.suppl_E.14
10.1093/eurheartj/18.suppl_F.11
10.1016/S0002-9149(00)00911-5
10.1016/S0149-2918(01)80086-2
10.1001/jama.1993.03510100061033
10.1016/S0140-6736(08)61237-4
10.1093/eurheartj/ehi886
10.1161/01.CIR.103.24.2994
10.1136/heartjnl-2011-301009
10.1093/eurheartj/17.suppl_F.9
10.1136/hrt.2007.126821
10.1016/S0002-9149(96)00737-0
10.1111/j.1755-5922.2010.00239.x
10.1345/aph.18334
10.1001/jama.293.14.1746
10.1016/0140-6736(92)91893-D
10.1016/S0140-6736(00)05060-1
10.1016/S0140-6736(08)60623-6
10.1053/euhj.1999.1993
10.2174/187152508784871945
10.1161/01.CIR.0000128736.57259.48
10.1378/chest.126.3_suppl.549S
10.1016/S0140-6736(99)07403-6
10.1161/01.CIR.91.11.2725
10.1093/eurheartj/ehp156
10.2217/nnm.11.179
10.1001/jama.286.4.442
10.3949/ccjm.71.1.20
10.2165/00063030-200721010-00008
10.1592/phco.27.11.1558
10.1161/01.CIR.0000103122.10021.F2
10.2165/00003495-199856010-00004
10.4172/2155-9880.1000e109
10.1056/NEJMoa0808276
10.1001/jama.297.12.1313-a
10.1016/S0002-9149(00)00874-2
10.1161/CIR.0b013e3182831a11
10.3949/ccjm.69.7.554
10.1016/S0140-6736(03)12113-7
10.1016/S0195-668X(02)00618-8
10.1161/CIR.0b013e3182742c84
10.1161/01.CIR.103.8.1171
10.2147/VHRM.S3848
10.1016/S0140-6736(04)17072-4
10.1583/04-1438.1
10.1161/01.CIR.95.2.351
ContentType Journal Article
Copyright 2013
2013 Published by Elsevier B.V. on behalf of Cardiological Society of India. 2013
Copyright_xml – notice: 2013
– notice: 2013 Published by Elsevier B.V. on behalf of Cardiological Society of India. 2013
DBID 6I.
AAFTH
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
5PM
DOA
DOI 10.1016/j.ihj.2013.08.032
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EndPage 585
ExternalDocumentID oai_doaj_org_article_a7965a36b4234137ac142ba5755befff
PMC3861063
24206881
10_1016_j_ihj_2013_08_032
S001948321300285X
1_s2_0_S001948321300285X
Genre Journal Article
Review
GroupedDBID ---
.1-
.FO
.GJ
.~1
0R~
1P~
1~.
2WC
4.4
457
4G.
53G
7-5
8P~
AAEDW
AAIKJ
AALRI
AAXUO
AAYWO
ABBQC
ABFRF
ABMAC
ABXDB
ACVFH
ADBBV
ADCNI
ADVLN
AEFWE
AEKER
AEUPX
AEVXI
AEXQZ
AFPUW
AFRHN
AFTJW
AGHFR
AGYEJ
AIGII
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
AOIJS
BAWUL
BCNDV
C1A
DIK
E3Z
EBS
EJD
F5P
FDB
FEDTE
FIRID
FNPLU
GBLVA
GROUPED_DOAJ
GX1
HVGLF
HYE
HZ~
M41
MO0
M~E
O-L
O9-
OA~
OK1
OL0
P-8
P-9
PC.
Q38
ROL
RPM
SDF
SEL
SSZ
UNMZH
XSB
Z5R
0SF
6I.
AACTN
AAFTH
AFCTW
NCXOZ
RIG
LCYCR
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
5PM
ID FETCH-LOGICAL-c5372-4cc0ffa62e34638cec0c6e1d258ab5d8da2d2e731f83672304e3067603c46853
IEDL.DBID .~1
ISSN 0019-4832
IngestDate Wed Aug 27 01:24:12 EDT 2025
Thu Aug 21 18:28:46 EDT 2025
Thu Apr 03 07:03:51 EDT 2025
Tue Jul 01 03:21:10 EDT 2025
Thu Apr 24 23:06:58 EDT 2025
Fri Feb 23 02:39:01 EST 2024
Sun Feb 23 10:19:07 EST 2025
Tue Aug 26 16:42:38 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords STEMI
Thrombolytics in AMI
AMI
CAD
Language English
License http://creativecommons.org/licenses/by-nc-nd/4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c5372-4cc0ffa62e34638cec0c6e1d258ab5d8da2d2e731f83672304e3067603c46853
OpenAccessLink https://www.sciencedirect.com/science/article/pii/S001948321300285X
PMID 24206881
PageCount 20
ParticipantIDs doaj_primary_oai_doaj_org_article_a7965a36b4234137ac142ba5755befff
pubmedcentral_primary_oai_pubmedcentral_nih_gov_3861063
pubmed_primary_24206881
crossref_citationtrail_10_1016_j_ihj_2013_08_032
crossref_primary_10_1016_j_ihj_2013_08_032
elsevier_sciencedirect_doi_10_1016_j_ihj_2013_08_032
elsevier_clinicalkeyesjournals_1_s2_0_S001948321300285X
elsevier_clinicalkey_doi_10_1016_j_ihj_2013_08_032
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20130901
PublicationDateYYYYMMDD 2013-09-01
PublicationDate_xml – month: 9
  year: 2013
  text: 20130901
  day: 1
PublicationDecade 2010
PublicationPlace India
PublicationPlace_xml – name: India
PublicationTitle Indian heart journal
PublicationTitleAlternate Indian Heart J
PublicationYear 2013
Publisher Elsevier, a division of RELX India, Pvt. Ltd
Elsevier
Publisher_xml – name: Elsevier, a division of RELX India, Pvt. Ltd
– name: Elsevier
References Alexander, Mehta, Mullasari (bib6) 2012; 98
Glover, Camacho, Wolfsdorf (bib57) 1999; 33
Weaver (bib16) 1996; 17
Retavase Prescribing information. Version RET08-201PDL BioPharma, Inc. EKR Therapeutics, Inc. Revised February 2009.
Widimsky, Groch, Zızko (bib46) 2000; 21
Armstrong, Granger, Van de (bib40) 2001; 103
Antman, Werf (bib14) 2004; 109
Longstaff, Williams, Thelwell (bib34) 2008; 6
Cannon (bib41) 2000; 85
Smalling, Bode, Kalfleisch (bib51) 1995; 91
(bib37) 1990; 336
O'Gara, Kushner, Ascheim (bib32) 2013; 127
Brunetti (bib68) 2012; 3
Surveillance of mortality and cardiovascular disease (CVD) related morbidity in Industrial settings. Accessed from
Califf (bib26) 1997; 18
Rihal, Jaffe, Holmes, Ting, Gersh, Bell (bib23) 2007; 297
Smalling (bib38) 1997; 18
Simpson, Asif, Siddiqui (bib59) 2007; 21
Schofield (bib24) 2005; 91
ISIS-2 Collaborative Group (bib25) 1988 Aug 13; 2
Cantor, Fitchett, Borgundvaag (bib63) 2009; 360
Cannon, McCabe, Gibson (bib21) 1997; 95
Hirsh, Anand, Jonathan (bib36) 2001; 103
Bonnefoy, Steg, Boutitie (bib45) 2009; 30
on 14th June 2012.
Otaal, Talwar (bib64) 2009; 61
Boden, Eagle, Granger (bib19) 2007; 50
Danchin, Coste, Ferrières (bib48) 2008; 118
(bib30) 1999; 354
Araújo, Tura, Brasileiro (bib67) 2008; 90
Horne, Weston, Quinn (bib60) 2009; 95
(bib1) 2011
Cannon, Brindis, Chaitman (bib17) 2013; 127
Levadot, Giugliano, Antman (bib39) 2001; 286
Verheugt (bib47) 2004; 364
Melandri, Vagnarelli, Calabrese (bib55) 2009; 5
Weaver (bib52) 1996; 17
Hoffmeister, Kastner, Szabo (bib61) 2000; 86
Perler (bib35) 2005; 12
Sharma, Ganguly (bib3) 2005; 1
The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology, Werf, Ardissino (bib18) 2003; 24
(bib27) 2001; 357
Hilleman, Tsikouris, Seals (bib54) 2007; 27
Davydov, Cheng (bib56) 2001; 23
Hiremath (bib8) 2011; 59
Mullasari (bib49) 2009; 61
McCarthy, Sazonova, Erdem (bib70) 2012 July; 7
Kaul, Bhatia (bib10) 2010; 132
Shah, Mathur (bib2) 2010; 132
Weaver, Cerqueira, Hallstrom (bib22) 1993; 270
(bib29) 1992; 339
Steg, James, Atar (bib50) 2012
Opie Lionel H, Gersh Bernard J. Drugs for the Heart. 7th ed.
Askari, Lincoff (bib28) 2002; 69
Bjorklund, Stenestrand, Lindback (bib69) 2006; 27
Menon, Harrington, Hochman (bib12) 2004; 126
Ellis, Brener (bib33) 2004; 71
Boersma, Steyerberg, Van der Vlugt (bib62) 1998 Jul; 56
Xavier, Pais, Devereaux, Xie (bib7) 2008; 371
Goodman, Menon, Cannon, Steg, Ohman, Harrington, American College of Chest Physicians (bib13) 2008; 133
White, Chew (bib15) 2008; 372
Keeley, Boura, Grines (bib20) 2003; 361
Steg, Bonnefoy, Chabaud (bib44) 2003; 108
Kaul, Gupta (bib9) 2004; 52
Accessed 02.11.12.
Califf, Newby (bib43) 1996; 78
Kunadian, Gibson (bib11) 2012; 30
Gupta, Misra, Vikram (bib4) 2009; 9
Wooster, Luzier (bib65) 1999; 33
Mehta, Alexander, Van de (bib42) 2005; 293
Mehta (10.1016/j.ihj.2013.08.032_bib42) 2005; 293
Brunetti (10.1016/j.ihj.2013.08.032_bib68) 2012; 3
Armstrong (10.1016/j.ihj.2013.08.032_bib40) 2001; 103
(10.1016/j.ihj.2013.08.032_bib1) 2011
Simpson (10.1016/j.ihj.2013.08.032_bib59) 2007; 21
White (10.1016/j.ihj.2013.08.032_bib15) 2008; 372
Weaver (10.1016/j.ihj.2013.08.032_bib22) 1993; 270
Otaal (10.1016/j.ihj.2013.08.032_bib64) 2009; 61
Sharma (10.1016/j.ihj.2013.08.032_bib3) 2005; 1
Alexander (10.1016/j.ihj.2013.08.032_bib6) 2012; 98
Wooster (10.1016/j.ihj.2013.08.032_bib65) 1999; 33
(10.1016/j.ihj.2013.08.032_bib29) 1992; 339
Smalling (10.1016/j.ihj.2013.08.032_bib38) 1997; 18
Kaul (10.1016/j.ihj.2013.08.032_bib9) 2004; 52
10.1016/j.ihj.2013.08.032_bib66
Hilleman (10.1016/j.ihj.2013.08.032_bib54) 2007; 27
ISIS-2 Collaborative Group (10.1016/j.ihj.2013.08.032_bib25) 1988; 2
Goodman (10.1016/j.ihj.2013.08.032_bib13) 2008; 133
Smalling (10.1016/j.ihj.2013.08.032_bib51) 1995; 91
Weaver (10.1016/j.ihj.2013.08.032_bib52) 1996; 17
Melandri (10.1016/j.ihj.2013.08.032_bib55) 2009; 5
Davydov (10.1016/j.ihj.2013.08.032_bib56) 2001; 23
Rihal (10.1016/j.ihj.2013.08.032_bib23) 2007; 297
Horne (10.1016/j.ihj.2013.08.032_bib60) 2009; 95
Antman (10.1016/j.ihj.2013.08.032_bib14) 2004; 109
Verheugt (10.1016/j.ihj.2013.08.032_bib47) 2004; 364
Gupta (10.1016/j.ihj.2013.08.032_bib4) 2009; 9
Schofield (10.1016/j.ihj.2013.08.032_bib24) 2005; 91
Ellis (10.1016/j.ihj.2013.08.032_bib33) 2004; 71
Cannon (10.1016/j.ihj.2013.08.032_bib21) 1997; 95
(10.1016/j.ihj.2013.08.032_bib37) 1990; 336
Bjorklund (10.1016/j.ihj.2013.08.032_bib69) 2006; 27
Levadot (10.1016/j.ihj.2013.08.032_bib39) 2001; 286
Cannon (10.1016/j.ihj.2013.08.032_bib41) 2000; 85
Bonnefoy (10.1016/j.ihj.2013.08.032_bib45) 2009; 30
Hiremath (10.1016/j.ihj.2013.08.032_bib8) 2011; 59
Boersma (10.1016/j.ihj.2013.08.032_bib62) 1998; 56
Shah (10.1016/j.ihj.2013.08.032_bib2) 2010; 132
Longstaff (10.1016/j.ihj.2013.08.032_bib34) 2008; 6
Kunadian (10.1016/j.ihj.2013.08.032_bib11) 2012; 30
O'Gara (10.1016/j.ihj.2013.08.032_bib32) 2013; 127
The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology (10.1016/j.ihj.2013.08.032_bib18) 2003; 24
Kaul (10.1016/j.ihj.2013.08.032_bib10) 2010; 132
Xavier (10.1016/j.ihj.2013.08.032_bib7) 2008; 371
Califf (10.1016/j.ihj.2013.08.032_bib26) 1997; 18
Askari (10.1016/j.ihj.2013.08.032_bib28) 2002; 69
Keeley (10.1016/j.ihj.2013.08.032_bib20) 2003; 361
(10.1016/j.ihj.2013.08.032_bib27) 2001; 357
Hoffmeister (10.1016/j.ihj.2013.08.032_bib61) 2000; 86
Weaver (10.1016/j.ihj.2013.08.032_bib16) 1996; 17
10.1016/j.ihj.2013.08.032_bib53
Cantor (10.1016/j.ihj.2013.08.032_bib63) 2009; 360
Califf (10.1016/j.ihj.2013.08.032_bib43) 1996; 78
Cannon (10.1016/j.ihj.2013.08.032_bib17) 2013; 127
Steg (10.1016/j.ihj.2013.08.032_bib50) 2012
Steg (10.1016/j.ihj.2013.08.032_bib44) 2003; 108
10.1016/j.ihj.2013.08.032_bib5
(10.1016/j.ihj.2013.08.032_bib30) 1999; 354
Danchin (10.1016/j.ihj.2013.08.032_bib48) 2008; 118
Menon (10.1016/j.ihj.2013.08.032_bib12) 2004; 126
Glover (10.1016/j.ihj.2013.08.032_bib57) 1999; 33
Widimsky (10.1016/j.ihj.2013.08.032_bib46) 2000; 21
Perler (10.1016/j.ihj.2013.08.032_bib35) 2005; 12
Hirsh (10.1016/j.ihj.2013.08.032_bib36) 2001; 103
10.1016/j.ihj.2013.08.032_bib58
McCarthy (10.1016/j.ihj.2013.08.032_bib70) 2012; 7
Mullasari (10.1016/j.ihj.2013.08.032_bib49) 2009; 61
Araújo (10.1016/j.ihj.2013.08.032_bib67) 2008; 90
Boden (10.1016/j.ihj.2013.08.032_bib19) 2007; 50
8960443 - Eur Heart J. 1996 Dec;17 Suppl F:9-15
11823998 - Eur Heart J. 1996 Sep;17 Suppl E:14-20
18591434 - Circulation. 2008 Jul 15;118(3):268-76
11413093 - Circulation. 2001 Jun 19;103(24):2994-3018
22076013 - Heart. 2012 Jan;98(1):15-7
15919654 - Heart. 2005 Jun;91 Suppl 3:iii7-11
17963464 - Pharmacotherapy. 2007 Nov;27(11):1558-70
9447335 - Eur Heart J. 1997 Dec;18 Suppl F:F11-6
19553646 - N Engl J Med. 2009 Jun 25;360(26):2705-18
10793176 - Am J Cardiol. 2000 Apr 27;85(8A):17C-22C
12517460 - Lancet. 2003 Jan 4;361(9351):13-20
22922416 - Eur Heart J. 2012 Oct;33(20):2569-619
8990405 - Am J Cardiol. 1996 Dec 19;78(12A):8-15
21150006 - Indian J Med Res. 2010 Nov;132:543-8
22624282 - J Assoc Physicians India. 2011 Dec;59 Suppl:49-50
12559937 - Eur Heart J. 2003 Jan;24(1):28-66
10332531 - Ann Pharmacother. 1999 Apr;33(4):416-9
18673235 - Cardiovasc Hematol Agents Med Chem. 2008 Jul;6(3):212-23
15827313 - JAMA. 2005 Apr 13;293(14):1746-50
18574277 - Chest. 2008 Jun;133(6 Suppl):708S-775S
20635760 - Indian Heart J. 2009 Sep-Oct;61(5):448-53
15173037 - Circulation. 2004 Jun 1;109(21):2480-6
15823070 - J Endovasc Ther. 2005 Apr;12(2):224-32
17765117 - J Am Coll Cardiol. 2007 Sep 4;50(10):917-29
20635766 - Indian Heart J. 2009 Sep-Oct;61(5):470-5
14740966 - Cleve Clin J Med. 2004 Jan;71(1):20, 23-5, 29-30 passim
9447334 - Eur Heart J. 1997 Dec;18 Suppl F:F2-10
11519775 - Clin Ther. 2001 Jul;23(7):982-97; discussion 981
14623806 - Circulation. 2003 Dec 9;108(23):2851-6
1975321 - Lancet. 1990 Jul 14;336(8707):65-71
2899772 - Lancet. 1988 Aug 13;2(8607):349-60
10200858 - Ann Pharmacother. 1999 Mar;33(3):318-24
9008448 - Circulation. 1997 Jan 21;95(2):351-6
21070617 - Cardiovasc Ther. 2012 Apr;30(2):e81-8
15380948 - Lancet. 2004 Sep 18-24;364(9439):1014-5
15383484 - Chest. 2004 Sep;126(3 Suppl):549S-575S
18440425 - Lancet. 2008 Apr 26;371(9622):1435-42
12109639 - Cleve Clin J Med. 2002 Jul;69(7):554-60
18707987 - Lancet. 2008 Aug 16;372(9638):570-84
17923462 - Heart. 2009 Apr;95(7):559-63
10475182 - Lancet. 1999 Aug 28;354(9180):716-22
18392380 - Arq Bras Cardiol. 2008 Feb;90(2):91-8
9664197 - Drugs. 1998 Jul;56(1):31-48
21150017 - Indian J Med Res. 2010 Nov;132:634-42
7758177 - Circulation. 1995 Jun 1;91(11):2725-32
10922430 - Am J Cardiol. 2000 Aug 1;86(3):263-8
17392234 - JAMA. 2007 Mar 28;297(12):1313; author reply 1314-5
8355383 - JAMA. 1993 Sep 8;270(10):1211-6
11425411 - Lancet. 2001 Jun 16;357(9272):1915-24
22348271 - Nanomedicine (Lond). 2012 Jul;7(7):1017-28
1347801 - Lancet. 1992 Mar 28;339(8796):753-70
17319107 - Vasc Health Risk Manag. 2005;1(3):217-25
19575817 - BMC Cardiovasc Disord. 2009;9:28
23357718 - Circulation. 2013 Mar 5;127(9):1052-89
15884459 - J Assoc Physicians India. 2004 Dec;52:986-9
11222483 - Circulation. 2001 Feb 27;103(8):1171-3
23247304 - Circulation. 2013 Jan 29;127(4):e362-425
19429632 - Eur Heart J. 2009 Jul;30(13):1598-606
11466123 - JAMA. 2001 Jul 25;286(4):442-9
17263591 - BioDrugs. 2007;21(1):65-8
16624832 - Eur Heart J. 2006 May;27(10):1146-52
10781354 - Eur Heart J. 2000 May;21(10):823-31
19436656 - Vasc Health Risk Manag. 2009;5(1):249-56
References_xml – volume: 61
  start-page: 470
  year: 2009
  end-page: 475
  ident: bib64
  article-title: Limitations of currently available thrombolytic therapy
  publication-title: Indian Heart J
– volume: 33
  start-page: 318
  year: 1999
  end-page: 324
  ident: bib65
  article-title: Reteplase: a new thrombolytic for the treatment of acute myocardial infarction
  publication-title: Ann Pharmacother
– volume: 7
  start-page: 1017
  year: 2012 July
  end-page: 1028
  ident: bib70
  article-title: Multifunctional nanoagent for thrombus-targeted fibrinolytic therapy
  publication-title: Nanomedicine (Lond)
– volume: 5
  start-page: 249
  year: 2009
  end-page: 256
  ident: bib55
  article-title: Review of tenecteplase (TNKase) in the treatment of acute myocardial infarction
  publication-title: Vasc Health Risk Manag
– volume: 357
  start-page: 1915
  year: 2001
  end-page: 1924
  ident: bib27
  article-title: Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trial
  publication-title: Lancet
– volume: 18
  start-page: F2
  year: 1997
  end-page: F10
  ident: bib26
  article-title: The GUSTO trial and the open artery theory
  publication-title: Eur Heart J
– volume: 85
  start-page: 17C
  year: 2000
  end-page: 22C
  ident: bib41
  article-title: Thrombolysis medication errors: benefits of bolus thrombolytic agents
  publication-title: Am J Cardiol
– volume: 126
  start-page: 549S
  year: 2004
  end-page: 575S
  ident: bib12
  article-title: Thrombolysis and adjunctive therapy in acute myocardial infarction: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
  publication-title: Chest
– volume: 108
  start-page: 2851
  year: 2003
  end-page: 2856
  ident: bib44
  article-title: Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty
  publication-title: Circulation
– volume: 133
  start-page: 708S
  year: 2008
  end-page: 775S
  ident: bib13
  article-title: Acute ST-segment elevation myocardial infarction: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition)
  publication-title: Chest
– volume: 361
  start-page: 13
  year: 2003
  end-page: 20
  ident: bib20
  article-title: Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials
  publication-title: Lancet
– volume: 56
  start-page: 31
  year: 1998 Jul
  end-page: 48
  ident: bib62
  article-title: Reperfusion therapy for acute myocardial infarction
  publication-title: Drugs
– volume: 360
  start-page: 2705
  year: 2009
  end-page: 2718
  ident: bib63
  article-title: Routine early angioplasty after fibrinolysis for acute myocardial infarction
  publication-title: N Engl J Med
– year: 2011
  ident: bib1
  publication-title: Global Atlas on Cardiovascular Disease Prevention and Control
– volume: 95
  start-page: 559
  year: 2009
  end-page: 563
  ident: bib60
  article-title: The impact of pre-hospital thrombolytic treatment on re-infarction rates: analysis of the Myocardial Infarction National Audit Project (MINAP)
  publication-title: Heart
– volume: 339
  start-page: 753
  year: 1992
  end-page: 870
  ident: bib29
  article-title: ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41,299 cases of suspected acute myocardial infarction. ISIS-3 (Third International Study of Infarct Survival) Collaborative Group
  publication-title: Lancet
– volume: 18
  start-page: F1
  year: 1997
  end-page: F16
  ident: bib38
  article-title: Pharmacological and clinical impact of the unique molecular structure of a new plasminogen activator
  publication-title: European Heart J
– volume: 30
  start-page: 1598
  year: 2009
  end-page: 1606
  ident: bib45
  article-title: Comparison of primary angioplasty and pre-hospital fibrinolysis in acute myocardial infarction (CAPTIM) trial: a 5-year follow-up
  publication-title: European Heart J
– volume: 95
  start-page: 351
  year: 1997
  end-page: 356
  ident: bib21
  article-title: TNK-tissue plasminogen activator in acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) 10A dose-ranging trial
  publication-title: Circulation
– volume: 297
  start-page: 1313
  year: 2007
  ident: bib23
  article-title: Percutaneous coronary intervention vs thrombolysis for ST-elevation myocardial infarction
  publication-title: JAMA
– volume: 61
  start-page: 448
  year: 2009
  end-page: 453
  ident: bib49
  article-title: Strategy of in ambulance thrombolysis followed by routine PCI in acute myocardial infarction
  publication-title: Indian Heart J
– volume: 12
  start-page: 224
  year: 2005
  end-page: 232
  ident: bib35
  article-title: Thrombolytic therapies: the current state of affairs
  publication-title: J Endovasc Ther
– volume: 270
  start-page: 1211
  year: 1993
  end-page: 1216
  ident: bib22
  publication-title: JAMA
– volume: 90
  start-page: 91
  year: 2008
  end-page: 98
  ident: bib67
  article-title: Cost-effectiveness of prehospital versus inhospital thrombolysis in acute myocardial infarction
  publication-title: Arq Bras Cardiol
– reference: Opie Lionel H, Gersh Bernard J. Drugs for the Heart. 7th ed.
– volume: 371
  start-page: 1435
  year: 2008
  end-page: 1442
  ident: bib7
  article-title: Treatment and outcomes of acute coronary syndromes in India (CREATE): a prospective analysis of registry data
  publication-title: Lancet
– volume: 336
  start-page: 65
  year: 1990
  end-page: 71
  ident: bib37
  article-title: GISSI-2: a factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction
  publication-title: Lancet
– volume: 69
  start-page: 554
  year: 2002
  end-page: 560
  ident: bib28
  article-title: GUSTO V: combination drug treatment of acute myocardial infarction
  publication-title: Cleveland Clin J Med
– volume: 293
  start-page: 1746
  year: 2005
  end-page: 1750
  ident: bib42
  article-title: Relationship of incorrect dosing of fibrinolytic therapy and clinical outcomes
  publication-title: JAMA
– volume: 17
  start-page: 9
  year: 1996
  end-page: 15
  ident: bib16
  article-title: The role of thrombolytic drugs in the management of myocardial infarction comparative clinical trials
  publication-title: Eur Heart J
– volume: 132
  start-page: 634
  year: 2010
  end-page: 642
  ident: bib2
  article-title: Surveillance of cardiovascular disease risk factors in India: the need and scope
  publication-title: Indian J Med Res
– volume: 23
  start-page: 982
  year: 2001
  end-page: 997
  ident: bib56
  article-title: Tenecteplase: a review
  publication-title: Clin Ther
– volume: 2
  start-page: 349
  year: 1988 Aug 13
  end-page: 360
  ident: bib25
  article-title: Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2
  publication-title: Lancet
– volume: 71
  start-page: 20
  year: 2004
  end-page: 37
  ident: bib33
  article-title: New fibrinolytic agents for MI: as effective as current agents, but easier to administer
  publication-title: Cleveland Clinic J Med
– volume: 91
  start-page: iii7
  year: 2005
  end-page: iii11
  ident: bib24
  article-title: Acute myocardial infarction: the case for pre-hospital thrombolysis with or without percutaneous coronary intervention
  publication-title: Heart
– volume: 78
  start-page: 8
  year: 1996
  end-page: 15
  ident: bib43
  article-title: How much do we gain by reducing time to reperfusion therapy?
  publication-title: Am J Cardiol
– volume: 86
  start-page: 263
  year: 2000
  end-page: 268
  ident: bib61
  article-title: Fibrin specificity and procoagulant effect related to the kallikrein-contact phase system and to plasmin generation with double-bolus reteplase and front-loaded alteplase thrombolysis in acute myocardial infarction
  publication-title: Am J Cardiol
– volume: 6
  start-page: 212
  year: 2008
  end-page: 223
  ident: bib34
  article-title: Fibrin binding and the regulation of plasminogen activators during thrombolytic therapy
  publication-title: Cardiovasc Hematol Agents Med Chem
– reference: Accessed 02.11.12.
– volume: 52
  start-page: 986
  year: 2004
  end-page: 989
  ident: bib9
  article-title: Management of acute myocardial infarction – primary angioplasty the treatment of choice!
  publication-title: JAPI
– volume: 364
  start-page: 1014
  year: 2004
  end-page: 1015
  ident: bib47
  article-title: Lyse now, stent later: the grace of GRACIA
  publication-title: Lancet
– volume: 21
  start-page: 65
  year: 2007
  end-page: 68
  ident: bib59
  article-title: Spotlight on reteplase in thrombotic occlusive disorders
  publication-title: Biodrugs
– volume: 354
  start-page: 716
  year: 1999
  end-page: 722
  ident: bib30
  article-title: Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial
  publication-title: Lancet
– volume: 27
  start-page: 1558
  year: 2007
  end-page: 1570
  ident: bib54
  article-title: Fibrinolytic agents for the management of ST-segment elevation myocardial infarction
  publication-title: Pharmacotherapy
– volume: 1
  start-page: 217
  year: 2005
  end-page: 225
  ident: bib3
  article-title: Premature coronary artery disease in Indians and its associated risk factors
  publication-title: Vasc Health Risk Manag
– volume: 30
  start-page: e81
  year: 2012
  end-page: e88
  ident: bib11
  article-title: Thrombolytics and myocardial infarction
  publication-title: Cardiovas Ther
– volume: 103
  start-page: 1171
  year: 2001
  end-page: 1173
  ident: bib40
  article-title: Bolus fibrinolysis: risk, benefit, and opportunities
  publication-title: Circulation
– volume: 17
  start-page: 14
  year: 1996
  end-page: 20
  ident: bib52
  article-title: Results of the RAPID 1 and RAPID 2 thrombolytic trials in acute myocardial infarction
  publication-title: European Heart J
– volume: 372
  start-page: 570
  year: 2008
  end-page: 584
  ident: bib15
  article-title: Acute myocardial infarction
  publication-title: Lancet
– volume: 27
  start-page: 1146
  year: 2006
  end-page: 1152
  ident: bib69
  article-title: Pre-hospital thrombolysis delivered by paramedics is associated with reduced time delay and mortality in ambulance-transported real-life patients with ST-elevation myocardial infarction
  publication-title: European Heart J
– volume: 132
  start-page: 543
  year: 2010
  end-page: 548
  ident: bib10
  article-title: Perspective on coronary interventions & cardiac surgeries in India
  publication-title: Indian J Med Res
– volume: 91
  start-page: 2725
  year: 1995
  end-page: 2732
  ident: bib51
  article-title: More rapid, complete, and stable coronary thrombolysis with bolus administration of reteplase compared with alteplase infusion in acute myocardial infarction
  publication-title: Circulation
– reference: on 14th June 2012.
– volume: 127
  year: 2013
  ident: bib32
  article-title: 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
  publication-title: Circulation
– volume: 24
  start-page: 28
  year: 2003
  end-page: 66
  ident: bib18
  article-title: Management of acute myocardial infarction in patients presenting with ST-segment elevation
  publication-title: European Heart J
– volume: 98
  start-page: 15
  year: 2012
  end-page: 17
  ident: bib6
  article-title: Systems of care for ST-elevation myocardial infarction in India
  publication-title: Heart
– volume: 9
  start-page: 28
  year: 2009
  ident: bib4
  article-title: Younger age of escalation of cardiovascular risk factors in Asian Indian subjects
  publication-title: BMC Cardiovasc Disord
– volume: 103
  start-page: 2994
  year: 2001
  end-page: 3018
  ident: bib36
  article-title: Guide to anticoagulant therapy: heparin: a statement for healthcare professionals from the AHA
  publication-title: Circulation
– volume: 127
  start-page: 1052
  year: 2013
  end-page: 1089
  ident: bib17
  article-title: 2013 ACCF/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes and coronary artery disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Acute Coronary Syndromes and Coronary Artery Disease Clinical Data Standards)
  publication-title: Circulation
– volume: 50
  start-page: 917
  year: 2007
  end-page: 929
  ident: bib19
  article-title: Reperfusion strategies in acute ST-segment elevation myocardial infarction: a comprehensive review of contemporary management options
  publication-title: J Am Coll Cardiol
– reference: Surveillance of mortality and cardiovascular disease (CVD) related morbidity in Industrial settings. Accessed from
– volume: 59
  start-page: 49
  year: 2011
  end-page: 50
  ident: bib8
  article-title: Future of thrombolytic therapy – an Indian context
  publication-title: JAPI
– reference: Retavase Prescribing information. Version RET08-201PDL BioPharma, Inc. EKR Therapeutics, Inc. Revised February 2009.
– volume: 286
  start-page: 442
  year: 2001
  end-page: 449
  ident: bib39
  article-title: Bolus fibrinolytic therapy in acute myocardial infarction
  publication-title: JAMA
– volume: 3
  start-page: 8
  year: 2012
  ident: bib68
  article-title: Tele-medicine for cardiovascular emergencies: ready for the prime time?
  publication-title: J Clin Exp Cardiolog
– volume: 21
  start-page: 823
  year: 2000
  end-page: 831
  ident: bib46
  article-title: Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory
  publication-title: European Heart J
– volume: 33
  start-page: 416
  year: 1999
  end-page: 419
  ident: bib57
  article-title: The use of alteplase in a newborn receiving extracorporeal membrane oxygenation
  publication-title: Ann Pharmacother
– volume: 118
  start-page: 268
  year: 2008
  end-page: 276
  ident: bib48
  article-title: Comparison of thrombolysis followed by broad use of percutaneous coronary intervention with primary percutaneous coronary intervention for ST-segment-elevation acute myocardial infarction: data from the French registry on acute ST-elevation myocardial infarction (FAST-MI)
  publication-title: Circulation
– year: 2012
  ident: bib50
  article-title: ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
  publication-title: European Heart J
– volume: 109
  start-page: 2480
  year: 2004
  end-page: 2486
  ident: bib14
  article-title: Pharmacoinvasive therapy: the future of treatment for ST-elevation myocardial infarction
  publication-title: Circulation
– volume: 91
  start-page: iii7
  year: 2005
  ident: 10.1016/j.ihj.2013.08.032_bib24
  article-title: Acute myocardial infarction: the case for pre-hospital thrombolysis with or without percutaneous coronary intervention
  publication-title: Heart
  doi: 10.1136/hrt.2004.058529
– volume: 133
  start-page: 708S
  year: 2008
  ident: 10.1016/j.ihj.2013.08.032_bib13
  article-title: Acute ST-segment elevation myocardial infarction: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition)
  publication-title: Chest
  doi: 10.1378/chest.08-0665
– volume: 1
  start-page: 217
  year: 2005
  ident: 10.1016/j.ihj.2013.08.032_bib3
  article-title: Premature coronary artery disease in Indians and its associated risk factors
  publication-title: Vasc Health Risk Manag
– volume: 18
  start-page: F2
  year: 1997
  ident: 10.1016/j.ihj.2013.08.032_bib26
  article-title: The GUSTO trial and the open artery theory
  publication-title: Eur Heart J
  doi: 10.1093/eurheartj/18.suppl_F.2
– volume: 52
  start-page: 986
  year: 2004
  ident: 10.1016/j.ihj.2013.08.032_bib9
  article-title: Management of acute myocardial infarction – primary angioplasty the treatment of choice!
  publication-title: JAPI
– volume: 33
  start-page: 318
  year: 1999
  ident: 10.1016/j.ihj.2013.08.032_bib65
  article-title: Reteplase: a new thrombolytic for the treatment of acute myocardial infarction
  publication-title: Ann Pharmacother
  doi: 10.1345/aph.18006
– volume: 9
  start-page: 28
  year: 2009
  ident: 10.1016/j.ihj.2013.08.032_bib4
  article-title: Younger age of escalation of cardiovascular risk factors in Asian Indian subjects
  publication-title: BMC Cardiovasc Disord
  doi: 10.1186/1471-2261-9-28
– volume: 50
  start-page: 917
  year: 2007
  ident: 10.1016/j.ihj.2013.08.032_bib19
  article-title: Reperfusion strategies in acute ST-segment elevation myocardial infarction: a comprehensive review of contemporary management options
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2007.04.084
– volume: 118
  start-page: 268
  year: 2008
  ident: 10.1016/j.ihj.2013.08.032_bib48
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.107.762765
– volume: 17
  start-page: 14
  year: 1996
  ident: 10.1016/j.ihj.2013.08.032_bib52
  article-title: Results of the RAPID 1 and RAPID 2 thrombolytic trials in acute myocardial infarction
  publication-title: European Heart J
  doi: 10.1093/eurheartj/17.suppl_E.14
– volume: 18
  start-page: F1
  year: 1997
  ident: 10.1016/j.ihj.2013.08.032_bib38
  article-title: Pharmacological and clinical impact of the unique molecular structure of a new plasminogen activator
  publication-title: European Heart J
  doi: 10.1093/eurheartj/18.suppl_F.11
– volume: 86
  start-page: 263
  year: 2000
  ident: 10.1016/j.ihj.2013.08.032_bib61
  article-title: Fibrin specificity and procoagulant effect related to the kallikrein-contact phase system and to plasmin generation with double-bolus reteplase and front-loaded alteplase thrombolysis in acute myocardial infarction
  publication-title: Am J Cardiol
  doi: 10.1016/S0002-9149(00)00911-5
– volume: 132
  start-page: 543
  year: 2010
  ident: 10.1016/j.ihj.2013.08.032_bib10
  article-title: Perspective on coronary interventions & cardiac surgeries in India
  publication-title: Indian J Med Res
– volume: 2
  start-page: 349
  year: 1988
  ident: 10.1016/j.ihj.2013.08.032_bib25
  article-title: Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2
  publication-title: Lancet
– volume: 23
  start-page: 982
  year: 2001
  ident: 10.1016/j.ihj.2013.08.032_bib56
  article-title: Tenecteplase: a review
  publication-title: Clin Ther
  doi: 10.1016/S0149-2918(01)80086-2
– volume: 132
  start-page: 634
  year: 2010
  ident: 10.1016/j.ihj.2013.08.032_bib2
  article-title: Surveillance of cardiovascular disease risk factors in India: the need and scope
  publication-title: Indian J Med Res
– volume: 61
  start-page: 470
  year: 2009
  ident: 10.1016/j.ihj.2013.08.032_bib64
  article-title: Limitations of currently available thrombolytic therapy
  publication-title: Indian Heart J
– volume: 270
  start-page: 1211
  year: 1993
  ident: 10.1016/j.ihj.2013.08.032_bib22
  publication-title: JAMA
  doi: 10.1001/jama.1993.03510100061033
– year: 2012
  ident: 10.1016/j.ihj.2013.08.032_bib50
  article-title: ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
  publication-title: European Heart J
– volume: 372
  start-page: 570
  year: 2008
  ident: 10.1016/j.ihj.2013.08.032_bib15
  article-title: Acute myocardial infarction
  publication-title: Lancet
  doi: 10.1016/S0140-6736(08)61237-4
– volume: 27
  start-page: 1146
  year: 2006
  ident: 10.1016/j.ihj.2013.08.032_bib69
  article-title: Pre-hospital thrombolysis delivered by paramedics is associated with reduced time delay and mortality in ambulance-transported real-life patients with ST-elevation myocardial infarction
  publication-title: European Heart J
  doi: 10.1093/eurheartj/ehi886
– ident: 10.1016/j.ihj.2013.08.032_bib58
– volume: 103
  start-page: 2994
  year: 2001
  ident: 10.1016/j.ihj.2013.08.032_bib36
  article-title: Guide to anticoagulant therapy: heparin: a statement for healthcare professionals from the AHA
  publication-title: Circulation
  doi: 10.1161/01.CIR.103.24.2994
– volume: 98
  start-page: 15
  year: 2012
  ident: 10.1016/j.ihj.2013.08.032_bib6
  article-title: Systems of care for ST-elevation myocardial infarction in India
  publication-title: Heart
  doi: 10.1136/heartjnl-2011-301009
– volume: 17
  start-page: 9
  year: 1996
  ident: 10.1016/j.ihj.2013.08.032_bib16
  article-title: The role of thrombolytic drugs in the management of myocardial infarction comparative clinical trials
  publication-title: Eur Heart J
  doi: 10.1093/eurheartj/17.suppl_F.9
– volume: 95
  start-page: 559
  year: 2009
  ident: 10.1016/j.ihj.2013.08.032_bib60
  article-title: The impact of pre-hospital thrombolytic treatment on re-infarction rates: analysis of the Myocardial Infarction National Audit Project (MINAP)
  publication-title: Heart
  doi: 10.1136/hrt.2007.126821
– volume: 78
  start-page: 8
  year: 1996
  ident: 10.1016/j.ihj.2013.08.032_bib43
  article-title: How much do we gain by reducing time to reperfusion therapy?
  publication-title: Am J Cardiol
  doi: 10.1016/S0002-9149(96)00737-0
– volume: 30
  start-page: e81
  year: 2012
  ident: 10.1016/j.ihj.2013.08.032_bib11
  article-title: Thrombolytics and myocardial infarction
  publication-title: Cardiovas Ther
  doi: 10.1111/j.1755-5922.2010.00239.x
– volume: 33
  start-page: 416
  year: 1999
  ident: 10.1016/j.ihj.2013.08.032_bib57
  article-title: The use of alteplase in a newborn receiving extracorporeal membrane oxygenation
  publication-title: Ann Pharmacother
  doi: 10.1345/aph.18334
– volume: 293
  start-page: 1746
  year: 2005
  ident: 10.1016/j.ihj.2013.08.032_bib42
  article-title: Relationship of incorrect dosing of fibrinolytic therapy and clinical outcomes
  publication-title: JAMA
  doi: 10.1001/jama.293.14.1746
– volume: 339
  start-page: 753
  year: 1992
  ident: 10.1016/j.ihj.2013.08.032_bib29
  publication-title: Lancet
  doi: 10.1016/0140-6736(92)91893-D
– volume: 357
  start-page: 1915
  year: 2001
  ident: 10.1016/j.ihj.2013.08.032_bib27
  article-title: Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trial
  publication-title: Lancet
  doi: 10.1016/S0140-6736(00)05060-1
– volume: 371
  start-page: 1435
  year: 2008
  ident: 10.1016/j.ihj.2013.08.032_bib7
  article-title: Treatment and outcomes of acute coronary syndromes in India (CREATE): a prospective analysis of registry data
  publication-title: Lancet
  doi: 10.1016/S0140-6736(08)60623-6
– volume: 59
  start-page: 49
  year: 2011
  ident: 10.1016/j.ihj.2013.08.032_bib8
  article-title: Future of thrombolytic therapy – an Indian context
  publication-title: JAPI
– volume: 21
  start-page: 823
  year: 2000
  ident: 10.1016/j.ihj.2013.08.032_bib46
  article-title: Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory
  publication-title: European Heart J
  doi: 10.1053/euhj.1999.1993
– volume: 6
  start-page: 212
  year: 2008
  ident: 10.1016/j.ihj.2013.08.032_bib34
  article-title: Fibrin binding and the regulation of plasminogen activators during thrombolytic therapy
  publication-title: Cardiovasc Hematol Agents Med Chem
  doi: 10.2174/187152508784871945
– volume: 109
  start-page: 2480
  year: 2004
  ident: 10.1016/j.ihj.2013.08.032_bib14
  article-title: Pharmacoinvasive therapy: the future of treatment for ST-elevation myocardial infarction
  publication-title: Circulation
  doi: 10.1161/01.CIR.0000128736.57259.48
– ident: 10.1016/j.ihj.2013.08.032_bib53
– volume: 126
  start-page: 549S
  year: 2004
  ident: 10.1016/j.ihj.2013.08.032_bib12
  article-title: Thrombolysis and adjunctive therapy in acute myocardial infarction: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
  publication-title: Chest
  doi: 10.1378/chest.126.3_suppl.549S
– volume: 354
  start-page: 716
  year: 1999
  ident: 10.1016/j.ihj.2013.08.032_bib30
  article-title: Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial
  publication-title: Lancet
  doi: 10.1016/S0140-6736(99)07403-6
– volume: 91
  start-page: 2725
  year: 1995
  ident: 10.1016/j.ihj.2013.08.032_bib51
  article-title: More rapid, complete, and stable coronary thrombolysis with bolus administration of reteplase compared with alteplase infusion in acute myocardial infarction
  publication-title: Circulation
  doi: 10.1161/01.CIR.91.11.2725
– volume: 90
  start-page: 91
  year: 2008
  ident: 10.1016/j.ihj.2013.08.032_bib67
  article-title: Cost-effectiveness of prehospital versus inhospital thrombolysis in acute myocardial infarction
  publication-title: Arq Bras Cardiol
– volume: 30
  start-page: 1598
  year: 2009
  ident: 10.1016/j.ihj.2013.08.032_bib45
  article-title: Comparison of primary angioplasty and pre-hospital fibrinolysis in acute myocardial infarction (CAPTIM) trial: a 5-year follow-up
  publication-title: European Heart J
  doi: 10.1093/eurheartj/ehp156
– volume: 7
  start-page: 1017
  year: 2012
  ident: 10.1016/j.ihj.2013.08.032_bib70
  article-title: Multifunctional nanoagent for thrombus-targeted fibrinolytic therapy
  publication-title: Nanomedicine (Lond)
  doi: 10.2217/nnm.11.179
– volume: 286
  start-page: 442
  year: 2001
  ident: 10.1016/j.ihj.2013.08.032_bib39
  article-title: Bolus fibrinolytic therapy in acute myocardial infarction
  publication-title: JAMA
  doi: 10.1001/jama.286.4.442
– volume: 61
  start-page: 448
  year: 2009
  ident: 10.1016/j.ihj.2013.08.032_bib49
  article-title: Strategy of in ambulance thrombolysis followed by routine PCI in acute myocardial infarction
  publication-title: Indian Heart J
– volume: 71
  start-page: 20
  year: 2004
  ident: 10.1016/j.ihj.2013.08.032_bib33
  article-title: New fibrinolytic agents for MI: as effective as current agents, but easier to administer
  publication-title: Cleveland Clinic J Med
  doi: 10.3949/ccjm.71.1.20
– volume: 21
  start-page: 65
  year: 2007
  ident: 10.1016/j.ihj.2013.08.032_bib59
  article-title: Spotlight on reteplase in thrombotic occlusive disorders
  publication-title: Biodrugs
  doi: 10.2165/00063030-200721010-00008
– volume: 27
  start-page: 1558
  year: 2007
  ident: 10.1016/j.ihj.2013.08.032_bib54
  article-title: Fibrinolytic agents for the management of ST-segment elevation myocardial infarction
  publication-title: Pharmacotherapy
  doi: 10.1592/phco.27.11.1558
– volume: 108
  start-page: 2851
  year: 2003
  ident: 10.1016/j.ihj.2013.08.032_bib44
  article-title: Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty
  publication-title: Circulation
  doi: 10.1161/01.CIR.0000103122.10021.F2
– volume: 56
  start-page: 31
  year: 1998
  ident: 10.1016/j.ihj.2013.08.032_bib62
  article-title: Reperfusion therapy for acute myocardial infarction
  publication-title: Drugs
  doi: 10.2165/00003495-199856010-00004
– volume: 3
  start-page: 8
  year: 2012
  ident: 10.1016/j.ihj.2013.08.032_bib68
  article-title: Tele-medicine for cardiovascular emergencies: ready for the prime time?
  publication-title: J Clin Exp Cardiolog
  doi: 10.4172/2155-9880.1000e109
– volume: 360
  start-page: 2705
  year: 2009
  ident: 10.1016/j.ihj.2013.08.032_bib63
  article-title: Routine early angioplasty after fibrinolysis for acute myocardial infarction
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa0808276
– volume: 297
  start-page: 1313
  year: 2007
  ident: 10.1016/j.ihj.2013.08.032_bib23
  article-title: Percutaneous coronary intervention vs thrombolysis for ST-elevation myocardial infarction
  publication-title: JAMA
  doi: 10.1001/jama.297.12.1313-a
– volume: 85
  start-page: 17C
  year: 2000
  ident: 10.1016/j.ihj.2013.08.032_bib41
  article-title: Thrombolysis medication errors: benefits of bolus thrombolytic agents
  publication-title: Am J Cardiol
  doi: 10.1016/S0002-9149(00)00874-2
– volume: 127
  start-page: 1052
  year: 2013
  ident: 10.1016/j.ihj.2013.08.032_bib17
  publication-title: Circulation
  doi: 10.1161/CIR.0b013e3182831a11
– volume: 69
  start-page: 554
  year: 2002
  ident: 10.1016/j.ihj.2013.08.032_bib28
  article-title: GUSTO V: combination drug treatment of acute myocardial infarction
  publication-title: Cleveland Clin J Med
  doi: 10.3949/ccjm.69.7.554
– volume: 361
  start-page: 13
  year: 2003
  ident: 10.1016/j.ihj.2013.08.032_bib20
  article-title: Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials
  publication-title: Lancet
  doi: 10.1016/S0140-6736(03)12113-7
– ident: 10.1016/j.ihj.2013.08.032_bib5
– volume: 24
  start-page: 28
  year: 2003
  ident: 10.1016/j.ihj.2013.08.032_bib18
  article-title: Management of acute myocardial infarction in patients presenting with ST-segment elevation
  publication-title: European Heart J
  doi: 10.1016/S0195-668X(02)00618-8
– ident: 10.1016/j.ihj.2013.08.032_bib66
– volume: 127
  year: 2013
  ident: 10.1016/j.ihj.2013.08.032_bib32
  article-title: 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
  publication-title: Circulation
  doi: 10.1161/CIR.0b013e3182742c84
– volume: 336
  start-page: 65
  year: 1990
  ident: 10.1016/j.ihj.2013.08.032_bib37
  article-title: GISSI-2: a factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction
  publication-title: Lancet
– volume: 103
  start-page: 1171
  year: 2001
  ident: 10.1016/j.ihj.2013.08.032_bib40
  article-title: Bolus fibrinolysis: risk, benefit, and opportunities
  publication-title: Circulation
  doi: 10.1161/01.CIR.103.8.1171
– volume: 5
  start-page: 249
  year: 2009
  ident: 10.1016/j.ihj.2013.08.032_bib55
  article-title: Review of tenecteplase (TNKase) in the treatment of acute myocardial infarction
  publication-title: Vasc Health Risk Manag
  doi: 10.2147/VHRM.S3848
– year: 2011
  ident: 10.1016/j.ihj.2013.08.032_bib1
– volume: 364
  start-page: 1014
  year: 2004
  ident: 10.1016/j.ihj.2013.08.032_bib47
  article-title: Lyse now, stent later: the grace of GRACIA
  publication-title: Lancet
  doi: 10.1016/S0140-6736(04)17072-4
– volume: 12
  start-page: 224
  year: 2005
  ident: 10.1016/j.ihj.2013.08.032_bib35
  article-title: Thrombolytic therapies: the current state of affairs
  publication-title: J Endovasc Ther
  doi: 10.1583/04-1438.1
– volume: 95
  start-page: 351
  year: 1997
  ident: 10.1016/j.ihj.2013.08.032_bib21
  article-title: TNK-tissue plasminogen activator in acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) 10A dose-ranging trial
  publication-title: Circulation
  doi: 10.1161/01.CIR.95.2.351
– reference: 22348271 - Nanomedicine (Lond). 2012 Jul;7(7):1017-28
– reference: 22076013 - Heart. 2012 Jan;98(1):15-7
– reference: 15173037 - Circulation. 2004 Jun 1;109(21):2480-6
– reference: 17392234 - JAMA. 2007 Mar 28;297(12):1313; author reply 1314-5
– reference: 10475182 - Lancet. 1999 Aug 28;354(9180):716-22
– reference: 17963464 - Pharmacotherapy. 2007 Nov;27(11):1558-70
– reference: 10922430 - Am J Cardiol. 2000 Aug 1;86(3):263-8
– reference: 19553646 - N Engl J Med. 2009 Jun 25;360(26):2705-18
– reference: 18440425 - Lancet. 2008 Apr 26;371(9622):1435-42
– reference: 23357718 - Circulation. 2013 Mar 5;127(9):1052-89
– reference: 18574277 - Chest. 2008 Jun;133(6 Suppl):708S-775S
– reference: 18673235 - Cardiovasc Hematol Agents Med Chem. 2008 Jul;6(3):212-23
– reference: 19429632 - Eur Heart J. 2009 Jul;30(13):1598-606
– reference: 17923462 - Heart. 2009 Apr;95(7):559-63
– reference: 15380948 - Lancet. 2004 Sep 18-24;364(9439):1014-5
– reference: 10200858 - Ann Pharmacother. 1999 Mar;33(3):318-24
– reference: 15823070 - J Endovasc Ther. 2005 Apr;12(2):224-32
– reference: 15919654 - Heart. 2005 Jun;91 Suppl 3:iii7-11
– reference: 2899772 - Lancet. 1988 Aug 13;2(8607):349-60
– reference: 20635766 - Indian Heart J. 2009 Sep-Oct;61(5):470-5
– reference: 12517460 - Lancet. 2003 Jan 4;361(9351):13-20
– reference: 1975321 - Lancet. 1990 Jul 14;336(8707):65-71
– reference: 23247304 - Circulation. 2013 Jan 29;127(4):e362-425
– reference: 18591434 - Circulation. 2008 Jul 15;118(3):268-76
– reference: 7758177 - Circulation. 1995 Jun 1;91(11):2725-32
– reference: 9008448 - Circulation. 1997 Jan 21;95(2):351-6
– reference: 21150006 - Indian J Med Res. 2010 Nov;132:543-8
– reference: 10793176 - Am J Cardiol. 2000 Apr 27;85(8A):17C-22C
– reference: 1347801 - Lancet. 1992 Mar 28;339(8796):753-70
– reference: 12109639 - Cleve Clin J Med. 2002 Jul;69(7):554-60
– reference: 9447334 - Eur Heart J. 1997 Dec;18 Suppl F:F2-10
– reference: 20635760 - Indian Heart J. 2009 Sep-Oct;61(5):448-53
– reference: 11425411 - Lancet. 2001 Jun 16;357(9272):1915-24
– reference: 19436656 - Vasc Health Risk Manag. 2009;5(1):249-56
– reference: 10781354 - Eur Heart J. 2000 May;21(10):823-31
– reference: 9447335 - Eur Heart J. 1997 Dec;18 Suppl F:F11-6
– reference: 21070617 - Cardiovasc Ther. 2012 Apr;30(2):e81-8
– reference: 15827313 - JAMA. 2005 Apr 13;293(14):1746-50
– reference: 14740966 - Cleve Clin J Med. 2004 Jan;71(1):20, 23-5, 29-30 passim
– reference: 22922416 - Eur Heart J. 2012 Oct;33(20):2569-619
– reference: 9664197 - Drugs. 1998 Jul;56(1):31-48
– reference: 21150017 - Indian J Med Res. 2010 Nov;132:634-42
– reference: 14623806 - Circulation. 2003 Dec 9;108(23):2851-6
– reference: 22624282 - J Assoc Physicians India. 2011 Dec;59 Suppl:49-50
– reference: 16624832 - Eur Heart J. 2006 May;27(10):1146-52
– reference: 18392380 - Arq Bras Cardiol. 2008 Feb;90(2):91-8
– reference: 17765117 - J Am Coll Cardiol. 2007 Sep 4;50(10):917-29
– reference: 11222483 - Circulation. 2001 Feb 27;103(8):1171-3
– reference: 18707987 - Lancet. 2008 Aug 16;372(9638):570-84
– reference: 17263591 - BioDrugs. 2007;21(1):65-8
– reference: 19575817 - BMC Cardiovasc Disord. 2009;9:28
– reference: 10332531 - Ann Pharmacother. 1999 Apr;33(4):416-9
– reference: 8960443 - Eur Heart J. 1996 Dec;17 Suppl F:9-15
– reference: 12559937 - Eur Heart J. 2003 Jan;24(1):28-66
– reference: 8355383 - JAMA. 1993 Sep 8;270(10):1211-6
– reference: 15383484 - Chest. 2004 Sep;126(3 Suppl):549S-575S
– reference: 8990405 - Am J Cardiol. 1996 Dec 19;78(12A):8-15
– reference: 11823998 - Eur Heart J. 1996 Sep;17 Suppl E:14-20
– reference: 15884459 - J Assoc Physicians India. 2004 Dec;52:986-9
– reference: 11466123 - JAMA. 2001 Jul 25;286(4):442-9
– reference: 11413093 - Circulation. 2001 Jun 19;103(24):2994-3018
– reference: 11519775 - Clin Ther. 2001 Jul;23(7):982-97; discussion 981
– reference: 17319107 - Vasc Health Risk Manag. 2005;1(3):217-25
SSID ssj0025490
Score 2.0099108
SecondaryResourceType review_article
SourceID doaj
pubmedcentral
pubmed
crossref
elsevier
SourceType Open Website
Open Access Repository
Index Database
Enrichment Source
Publisher
StartPage 566
SubjectTerms AMI
CAD
Cardiovascular
Combined Modality Therapy
Coronary Artery Disease - diagnostic imaging
Coronary Artery Disease - drug therapy
Coronary Artery Disease - mortality
Evidence-Based Medicine
Female
Fibrinolytic Agents - adverse effects
Fibrinolytic Agents - therapeutic use
Hemorrhage - chemically induced
Hemorrhage - epidemiology
Humans
India
Male
Myocardial Infarction - diagnosis
Myocardial Infarction - drug therapy
Myocardial Infarction - mortality
Myocardial Infarction - therapy
Myocardial Reperfusion - methods
Prognosis
Radiography
Randomized Controlled Trials as Topic
Risk Assessment
Role
Sponsored
STEMI
Survival Analysis
Thrombolytic Therapy - adverse effects
Thrombolytic Therapy - methods
Thrombolytics in AMI
Treatment Outcome
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1JT90wELYqDlUvVaHbY5MPPVWKmniLww1QEVSiBxbp3SzbscVDkKD34MC_Z8ZZRCQEF66JHTvjsecbe_wNIb_KWPmiqmxmdeCZ4E5mlcYBcbIuY1EDCk4Bsv_V8aX4N5fzZ6m-MCasowfuBPfHlpWSlisHdh8W3NL6QjBnAWVIF2KMuPqCzRucqd7VAq-nu3xSVLhdxobzzBTZtbi6xpgunrg7OZtYpETc_7JhmgZNPrNCR1_I5x4-0v2u2-vkQ2g2yMfT_oD8Kzk7a28CbSPF9Ae3rk2EI3TR0GW4C8v4gHtjtLtz9UgBr9LbMfwFa-2fnuzRkwZ1hiLNEzjS7TdycfT34vA469MmZF7ykmXC-zxGq1jgAmaXDz73KoDYpbYwArq2rGah5EXUXJW4KRzQb1A590KB9f5O1pq2CT8JDbYqhNM1zOooAJi5wCy3Tii8EOu1nJF8kJzxPaU4Zra4MUPs2LUBYRsUtsFsl5zNyO-xyl3Hp_Fa4QMcjrEgUmGnB6AgplcQ85aCzAgbBtMMt01hfYQPLV5ruXypUlj1M3xlCrNiJjfnqGKoYXgsyLScz4gYa_YgpgMnbzX4o1Ov8WcBO2FCoAK6MlG8iTSmb5rFVSII5xpAseKb7yG-LfKJpQwgGFa3Tdbulw9hB3DYvdtNU-4JLXstLw
  priority: 102
  providerName: Directory of Open Access Journals
Title Role of thrombolysis in reperfusion therapy for management of AMI: Indian scenario
URI https://www.clinicalkey.com/#!/content/1-s2.0-S001948321300285X
https://www.clinicalkey.es/playcontent/1-s2.0-S001948321300285X
https://dx.doi.org/10.1016/j.ihj.2013.08.032
https://www.ncbi.nlm.nih.gov/pubmed/24206881
https://pubmed.ncbi.nlm.nih.gov/PMC3861063
https://doaj.org/article/a7965a36b4234137ac142ba5755befff
Volume 65
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwELYQB9RL1dLX9oF86KlSSuJXkt4oAkElekBU2ptlO3YJgmS1C4de-ts74zgRURGVes3GG2dm7PnG-WaGkI9lqF1R1yYzleeZ4FZmdYUKsbIpQ9EACo4E2e_q5If4tpTLLXI45sIgrTLt_cOeHnfrdGU_SXN_1baY4wsBODba4Rg4yCVmsIsSrfzz74nmgfHPkIZS1HhwxsYvm5Hj1V5eIbuLxyqenM18Uyzh_7CLmtMn7_mj42fkaQKS9GCY63Oy5btdsnOWPpW_IOfn_bWnfaDYCOHG9rH0CG07uvYrvw53eEpGh-yrXxSQK72ZiDA46uDs9As97dB6KBZ8gpC6f0kujo8uDk-y1EAhc5KXLBPO5SEYxTwXsM6cd7lTHhQgKwO6qBrDGuZLXoSKqxKPhz1GECrnTijw46_Idtd3_g2h3tSFsFUD6zsIgGjWM8ONFQpTY10lFyQfJaddKi6OPS6u9cgiu9IgbI3C1tj3krMF-TQNWQ2VNR67-SuqY7oRi2LHC_36p05WoU1ZK2m4sgARwTeXxhWCWQOAVFofQlgQNipTj3mnsFPCH7WPPbl8aJDfpLW-0YXeMJ3rv-xxQcQ0cmbS_3rg68G8ppcFFIWtgQqYyszwZtKY_9K1l7FUOK8AHiv-9v-m8o48YbH7B1Lq3pPt2_Wd_wAY7NbuxUW2F08w_gCcvi4e
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZKkYALKu8FCj5wQgpNbMdJuJWq1S50e6gWaW-W7dhtqjZZ7bYHLvx2ZpyHGlEViWsSJ848PN_Y8yDkU-YLmxSFjnTueCS4SaMiR4aYtMx8UgIKDgGyJ3L6U3xfpsstctDnwmBYZbf2t2t6WK27K3sdNfdWVYU5vuCAY6Mdjo5DunxAHgpQX9TOL7-HOA90gNo8lKTAnTPWH22GIK_q_ALDu3go48nZyDiFGv5326hx_OQtg3S0Q552SJLut5N9RrZc_Zw8mndn5S_I6Wlz6WjjKXZCuDJNqD1Cq5qu3cqt_Q1uk9E2_eoXBehKr4ZIGBy1P599pbMaxYdixSfwqZuXZHF0uDiYRl0HhcimPGORsDb2XkvmuABFs87GVjrgQJprYEZealYyl_HE51xmuD_s0IWQMbdCgiF_RbbrpnZvCHW6SITJS1BwLwCjGcc010ZIzI21eTohcU85Zbvq4tjk4lL1YWQXCoitkNgKG19yNiGfhyGrtrTGfQ9_Q3YMD2JV7HChWZ-pTiyUzgqZai4NYEQwzpm2iWBGAyJNjfPeTwjrman6xFNYKuFF1X1fzu4a5Dadsm9UojZMxeovgZwQMYwcyfS_Pvi6Fa_hZwFGYW-gBKYyErwRNcZ36uo81ArnOeBjyd_-31Q-ksfTxfxYHc9OfrwjT1hoBYLxde_J9vX6xu0CILs2H4LC_QGYATBE
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Role+of+thrombolysis+in+reperfusion+therapy+for+management+of+AMI%3A+Indian+scenario&rft.jtitle=Indian+heart+journal&rft.au=Dalal%2C+Jamshed&rft.au=Sahoo%2C+Prasant+Kumar&rft.au=Singh%2C+Rakesh+Kumar&rft.au=Dhall%2C+Anil&rft.date=2013-09-01&rft.pub=Elsevier%2C+a+division+of+RELX+India%2C+Pvt.+Ltd&rft.issn=0019-4832&rft.volume=65&rft.issue=5&rft.spage=566&rft.epage=585&rft_id=info:doi/10.1016%2Fj.ihj.2013.08.032&rft.externalDocID=S001948321300285X
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F00194832%2FS0019483213X00069%2Fcov150h.gif